Milemark Capital — Investment Thesis & Preferences

Milemark Capital Research

Investment Thesis

Milemark Capital (stylized milemark•capital) is a Cambridge, Massachusetts-based early-stage venture capital firm founded in 2022 by four partners with deep ties to MIT and Harvard. The firm invests in early-stage diverse teams born of innovation hubs, building scalable businesses differentiated and defended by proprietary AI systems, models, and data.

The investment thesis rests on three interconnected pillars:

Applied Artificial Intelligence: The fund believes we are at a unique inflection point where applied AI unlocks immediate solutions to enterprise and industry pain points. They favor opportunities where AI is high leverage — where productivity, innovation, and new business gains from AI are highest. The fund is explicitly sector-agnostic but always requires a meaningful AI differentiation.
Diversity: Milemark believes the best opportunities are unlocked when entrepreneurs can relate to their investors. The team holds that diverse talent is evenly distributed across all demographics and backgrounds, and diverse founding teams increase innovation and improve financial performance. The firm actively champions and supports diverse founders with grit and passion who solve hard problems through their unique worldview.
Innovation Hubs: The team is embedded in the square mile between MIT and Harvard. The partners have strong integration as professors, researchers, and mentors at these institutions. They have access to dozens of exclusive startup events and are regularly recruited as mentors for on-campus entrepreneurship programs such as MIT Delta V.

Stage Focus

Milemark Capital invests at the early stage, primarily at the Pre-Seed and Seed stages. Their portfolio companies are mostly pre-revenue or early-revenue startups emerging from the MIT/Harvard ecosystem and other top research universities. The firm positions itself as a catalyst fund helping founders transition from academic life into commercialized ventures.

Check Size

Check size is not publicly disclosed. Given the firm's early-stage focus and portfolio composition (mostly pre-seed and seed stage companies from academic environments), check sizes are estimated in the range of $250K–$2M. No fund size or AUM information is publicly available.

Sector Focus

While the fund is sector-agnostic, the portfolio reveals strong sector clustering:

Healthcare AI and Digital Health: Piction Health (dermatology AI), Otomo Health (AI-native healthcare CRM), Empallo (cardiovascular AI care)
Biotech and Life Sciences: Absentia Labs (drug discovery AI), Collagio Bio (RNA therapeutics with AI-enhanced polynucleotide engineering), Stealth-BioTech (computational protein design)
Climate and Clean Energy: Gaia AI (forest management + carbon credits), Hera Materials / Atacama Biomaterials (low-carbon recyclable materials), Lamarr.AI (AI-powered building diagnostics for Net Zero)
Semiconductors and Hardware: Vertical Semiconductors (Vertical GaN power for AI data centers), Diffraqtion (quantum visual AI hardware for satellites and aerospace)
Enterprise Software and AI: Catalan AI (B2B dynamic pricing for SMBs), Otomo Health (healthcare workflow automation)
Developer Tools and AI Infrastructure: CLIKA (AI model compression for hardware deployment), Lumif.ai (AI agents marketplace and infrastructure)
Agriculture Technology: Adaviv (plant-level intelligence for cultivation optimization)
Gaming: Bitpart AI (AI character models for game development)

Lead Tendency

Lead tendency is not publicly disclosed. Given the early-stage focus and small fund size, the firm likely leads or co-leads rounds at Seed stage in select portfolio companies.

Recent Activity

The firm has been actively building its portfolio since 2022. Events attended and sponsored in 2024-2025 include:

BIG.AI@MIT Conference (sponsor and speaker)
SF Tech Week 2024
New England Venture Summit 2024
MIT Female Pitch Competition (sponsor)
MIT Women's Conference 2025
Endeavor Connect at Ventures
MIT Climate & Energy Prize Competition 2025 (Seb as mentor)

The portfolio appears to be actively growing with 16+ companies as of early 2026.

Portfolio Highlights

Healthcare AI:

Piction Health (pictionhealth.com): AI to elevate every doctor to have dermatologist-level expertise. Builds the industry's first AI-based tool for accurately distinguishing skin diseases.
Otomo Health (otomohealth.com): AI-native CRM and end-to-end solution combining AI agents with workflow automation for healthcare clinic front and back office operations.
Empallo (empallo.com): AI-powered cardiovascular care, making cardiovascular care accessible while improving health outcomes.

Biotech:

Absentia Labs (absentia.bio): AI drug discovery platform using models trained on human trial data to predict drug toxicity/efficacy, compressing 10-12 year discovery timelines to months.
Collagio Bio (Collage Bio): AI-enhanced polynucleotide engineering for novel RNA therapeutics; combining durability of gene editing with reversible disease modulation.

Climate:

Gaia AI (gaia-ai.eco): LiDAR and computer vision for forest management optimization, plus carbon credit monetization marketplace.
Hera Materials / Atacama Biomaterials (heramaterials.com): Low-cost, low-carbon, recyclable, compostable, durable materials using AI and robotics (including Woodpack product).
Lamarr.AI (lamarr.ai): AI-powered building envelope diagnostics for Net Zero transition; identifies infrastructure flaws causing energy waste.

Deep Tech / Hardware:

Vertical Semiconductors (verticalsemi.com): Patented Vertical GaN technology for power supplies in AI data centers — cuts energy loss by 33%, saves 50% rack space.
Diffraqtion (diffraqtion.com): Quantum visual AI hardware breaking the diffraction limit; cameras that see 20x further, AI running 1000x faster, technology developed with DARPA and NASA.

AI Infrastructure:

CLIKA (clika.io): Automated Compression Engine (ACE) that compresses months of AI model hardware productization to minutes.
Lumif.ai: Open infrastructure and marketplace to build, use, and capitalize fully autonomous AI professionals (agents).

Team

Founding Partners:

Sebastian Barriga: Private equity and angel investor with nine years at Carlyle South America ($358M Fund), invested in 6 companies in 3 countries, exited largest investment in 2020 for $400M. Former Investment Banking with Citigroup in NY and Mexico. 7x Board Member. Angel investor in 10+ startups. MIT Assistant Lecturer, MIT Delta V participant. YPO member.
Adela Jamal: Silicon Valley tech startup operator, DEI and women's advancement champion. Technology consultant with VC experience. Ex-Sony Pictures executive (technology and workforce-of-the-future division). Deep expertise launching and leading global platforms for diverse groups. AllRaise Steering Committee member. Angel investor.
Sinan Aral: AI expert and global authority on business analytics. Award-winning researcher and entrepreneur. Chaired, tenured Professor at MIT (David Austin Professor of Management). Co-founder of Series-A venture fund Manifest Capital. Co-founder of two startups with two successful exits. Published the second most influential scientific article of 2018 on the cover of Science.
Michael Lipton: Serial entrepreneur with expertise in commercializing technology. Founded, led, and scaled three companies; most recent to $35M revenue. Expert in taking companies from zero-to-one including customer discovery, product roadmapping, GTM, and business development. Coveted startup mentor and advisor, currently serving on 3 boards. Ex-Goldman Sachs. Press coverage in NY Times, Bloomberg, WSJ, CNBC, BBC.

Advisory Board

The firm has assembled an impressive advisory board with deep PE/VC, academic, and operational expertise:

Jason Thomas (Investment Strategy & Global Research)
Chris Finn (Experienced Investor, IC Chairman, former COO at Carlyle)
Norma Kuntz (CEO Gordon Brothers | COO & CFO of Global PE at Carlyle)
Brian Trelstad (Investor at Bridges & Acumen | HBS Senior Lecturer)
Peter Kellner (Founder Richmond Global & Endeavor)
John Harthorne (Investor & Founder 2LVC | MassChallenge Co-Founder)
Jim Baum (Growth & GTM Expert | Experienced Tech Growth CEO)
Erin Scott (Entrepreneurial Strategy | MIT Lecturer)
Daniela Ruiz-Massieu (Entrepreneurship at ITAM and MIT)
Monty Sharma (Entrepreneur | MassDigi MD at WPI)
Miguel Paredes (Applied AI Expert | VP Data Science Albertsons)
Alexis Montecinos (Applied AI Expert | MIT Lecturer)
Luis Lamb (Neurosymbolic AI Expert, PhD in CS)

Geographic Focus

Primarily US, with coverage across major innovation and startup hubs: Chicago, New York, Atlanta, Austin, Los Angeles, San Francisco, and Boston/Cambridge. The firm is headquartered in Cambridge, MA with the team embedded in the MIT/Harvard ecosystem. Global reach is expected given the advisory board's Latin American and European connections (Carlyle South America, Grupo Romero, Credicorp).

Decision Process

Not publicly disclosed. The firm has four founding partners suggesting a partnership-based decision model. The strong advisory board with IC expertise (Chris Finn, former Carlyle COO) suggests a structured investment committee process.

Founder Preferences

Milemark actively champions diverse founding teams, particularly those emerging from top research universities (MIT, Harvard) and other innovation hubs. They value technical founders with AI expertise who are solving large, impactful problems in enterprise and industry verticals. Female founders and underrepresented groups are particularly supported, evidenced by their sponsorship of MIT Female Pitch Competition and AllRaise involvement.